MTOR and mantle cell lymphoma: For example, temsirolimus could significantly prolong progression-free survival of mantle cell lymphoma (MCL) patients by inhibiting the mechanistic target of rapamycin (mTOR) protein, a post-translational autophagy regulator [7].